UBS AM’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163M Buy
2,541,393
+20,180
+0.8% +$1.33M 0.03% 418
2026
Q1
$179M Buy
2,521,213
+30,199
+1% +$2.38M 0.04% 389
2025
Q4
$204M Sell
2,491,014
-50,955
-2% -$3.97M 0.04% 355
2025
Q3
$191M Sell
2,541,969
-466,570
-16% -$34.8M 0.04% 365
2025
Q2
$223M Sell
3,008,539
-320,468
-10% -$22.3M 0.05% 371
2025
Q1
$269M Buy
3,329,007
+3,911
+0.1% +$336K 0.07% 297
2024
Q4
$260M Buy
3,325,096
+416,386
+14% +$35.4M 0.06% 300
2024
Q3
$273M Sell
2,908,710
-9,088
-0.3% -$763K 0.07% 263
2024
Q2
$227M Buy
2,917,798
+997,377
+52% +$81.4M 0.07% 272
2024
Q1
$175M Buy
1,920,421
+366,978
+24% +$30.5M 0.06% 306
2023
Q4
$120M Buy
1,553,443
+96,071
+7% +$6.73M 0.05% 385
2023
Q3
$99.2M Buy
1,457,372
+182,035
+14% +$13.2M 0.04% 405
2023
Q2
$105M Hold
1,275,337
0.05% 378
2023
Q1
$105M Buy
+1,275,337
New +$91.1M 0.05% 378

Other funds holding GEHC

UBS AM's GEHC Position: Q2 2026 in Review

UBS AM increased its GE HealthCare (GEHC) stake by 0.8% in Q2 2026, buying an estimated $1.33M and bringing the position to 2,541,393 shares worth $163M. The position accounts for 0.03% of the portfolio, ranked #418.

UBS AM first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $273M in Q3 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • UBS AM held 2,541,393 shares of GE HealthCare worth $163M as of Q2 2026.
  • UBS AM bought 20,180 GE HealthCare shares in Q2 2026, an estimated $1.33M.
  • GE HealthCare made up 0.03% of UBS AM's portfolio in Q2 2026, its #418 holding.
  • UBS AM first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • UBS AM's GE HealthCare position peaked at $273M in Q3 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.